* Q4 loss/shr $0.24 vs est. loss/shr $0.16
* Q4 rev rise 32 pct
* Shares fall as much as 27 pct
March 12 (Reuters) - Cytori Therapeutics Inc (CYTX.O) posted a wider-than-expected quarterly loss, hurt by higher expenses, sending shares down as much as 27 percent.
For the fourth quarter, the company posted a net loss of $9.5 million, or 24 cents a share, compared with $6.5 million, or 22 cents a share, a year ago.
Total revenue rose 32 percent at $2.9 million. Operating expenses rose about 42 percent to $11.2 million.
Analysts on average expected the company to post a loss of 16 cents a share, on revenue of $1.9 million, according to Thomson Reuters I/B/E/S.
Shares of the company, which fell 27 percent to $5.50 in early trade, pared some losses and were down 18 percent at $6.19 in morning trade on Nasdaq. (Reporting by Krishnakali Sengupta in Bangalore; Editing by Bijoy Koyitty) ((email@example.com; within U.S. +1 646 223 8780; outside U.S. +91 80 4135 5800; Reuters Messaging: firstname.lastname@example.org))